ApniCure is a private Redwood City, Calif.-based medical device company focused on developing and commercializing novel home-use devices incorporating a proprietary platform technology called Oral Pressure Therapy (OPT) for the treatment of obstructive sleep apnea (OSA) and other sleep related disorders. ApniCure has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Winx® Sleep Therapy System in the United States for home-use treatment of OSA. The Winx system is the first in a series of products that ApniCure plans to introduce. ApniCure aims to improve the lives of the millions of patients suffering from sleep disordered breathing, by providing them with quality, innovative, effective sleep therapies.
Company Growth (employees)
Redwood City, US
Size (employees)
30 (est)
ApniCure was founded in 2007 and is headquartered in Redwood City, US

Key People at ApniCure

Glen French

Glen French

President and CEO
Dan George

Dan George

Vice President of Finance
Chris Daniel

Chris Daniel

Executive Vice President of Operations, Founder
Jed Crowe

Jed Crowe

Director, Research and Development, Founder
Jonathan Podmore

Jonathan Podmore

Vice President of Research and Development, Founder

ApniCure Office Locations

ApniCure has an office in Redwood City
Redwood City, US (HQ)
900 Chesapeake Drive,

ApniCure Metrics

Summary Metrics

Founding Date


Total Funding

$20.9 m

Latest funding size

$15.8 m

Time since last funding

about 1 year


ApniCure's latest funding round in March 2016 was reported to be $15.8 m. In total, ApniCure has raised $20.9 m

ApniCure Company Life

You may also be interested in